Circulation Journal
Online ISSN : 1347-4820
Print ISSN : 1346-9843
ISSN-L : 1346-9843

この記事には本公開記事があります。本公開記事を参照してください。
引用する場合も本公開記事を引用してください。

Aortic Root Dilatation and Aortic Stiffness in Patients With Single Ventricular Circulation
Takuro KojimaSeiko KuwataClara KurishimaYoichi IwamotoHirofumi SaikiHirotaka IshidoSatoshi MasutaniHideaki Senzaki
著者情報
ジャーナル フリー HTML 早期公開

論文ID: CJ-13-1264

この記事には本公開記事があります。
詳細
Abstract

Background: This study tested the hypothesis that aortic stiffness is increased more in patients with single ventricular (SiV) circulation and dilated aorta than in those without aortic dilatation, and that aortic stiffness is an independent determinant of aortic dilatation in this type of patient.

Methods and Results: Pulse wave velocity (PWV) and aortic size were measured during catheterization in 56 consecutive patients with SiV circulation (aortic dilatation, n=31 [observed/expected aortic root diameter >1.5]; without aortic dilatation, n=25). PWV was found to be significantly higher in the dilatation group than in the non-dilatation group (483.6±10.3 vs. 394.0±8.9 cm/s, P<0.001) after controlling for age and aortic pressure, factors known to influence PWV (P<0.001, analysis of covariance). There was a strong positive correlation between aortic root diameter and PWV (P<0.001). Multivariate analysis adding aortic flow (index of aortic volume load) to independent variables in 25 pre-Glenn patients with directly calculated aortic flow volume showed that PWV was an independent determinant of aortic dilatation (P<0.001).

Conclusions: In patients with SiV circulation and dilated aorta, aortic stiffness is increased and is an independent determinant of aortic dilatation. To improve prognosis of Fontan circulation, further studies on whether aortic stiffness modulation reduces the progression of aortic dilatation and resultant aortic regurgitation are warranted.

Progressive aortic dilatation can occur and may lead to aortic regurgitation in patients with tetralogy of Fallot (TOF).14 Intrinsic histological abnormalities in the aortic media, best characterized by elastic fiber disruption, are thought to be a major cause of this pathologic phenomenon.5,6 Disruption of elastic fibers in the aortic media in turn suggests a decrease in the elastic nature of the aortic wall. Indeed, several studies demonstrated increased aortic stiffness and its significant association with aortic dilatation in TOF patients.5,712 Notably, abnormal medial histopathology can also be present in congenital heart disease (CHD) of single ventricular (SiV) circulation, and aortic dilatation is also known to occur in this disease,5,1315 indicating possible aortic stiffening and its significant association with aortic dilatation in these patients. In addition to abnormal aortic medial pathology, aortic volume load induced by right-to-left shunt and/or aortopulmonary shunt has been suggested to play a synergistic role in the development of aortic dilatation in TOF.1 It is also of note that aortic volume overload is often accompanied by SiV circulation, and thus may contribute to the development of aortic dilatation in SiV circulation as well as in TOF. The underlying mechanisms of aortic dilatation observed in SiV circulation, however, are unknown. The present study was therefore conducted to test the hypothesis that aortic stiffness is increased more in patients with SiV circulation and a dilated aorta than in those without aortic dilatation, and that aortic stiffness is an independent determinant of aortic dilatation in this patient type regardless of the presence of aortic volume load.

Methods

The study was approved by Institutional Review Board of Saitama Medical University (No.12-024, International Medical Center, Saitama Medical University).

Patients

The study included 56 consecutive pediatric patients with SiV circulation who underwent cardiac catheterization at International Medical Center, Saitama Medical University. These patients were divided into 2 groups according to the presence or absence of aortic dilatation, defined as observed/expected aortic root diameter >1.5, as follows: a dilatation group, n=31; and a non-dilatation group, n=25.

Measurements

The ascending aortic diameter (AOD) of the sinotubular junction was obtained at end diastole from 2-dimensional transthoracic echocardiograms obtained at the time of catheterization and was indexed to the normal reference value for Japanese children.16 Aortic pressure was measured using a high-fidelity micromanometer mounted on a 0.014-in guidewire inserted in a 4-Fr pigtail catheter. As an index of aortic stiffness, pulse wave velocity (PWV)5,6 was measured as the catheter was withdrawn from the ascending aorta to the descending aorta at the level of the diaphragm. The distance between the 2 aortic levels was measured directly from the length of the catheter withdrawn outside the patient’s body. PWV was then calculated by dividing the distance between the ascending and descending aorta by the time delay between the rapid upstroke of the feet of recorded pulse waves at each site. During the catheter drawback from the ascending to the descending aorta (within 1 or 2 s), little change in heart rate and blood pressure was confirmed. Therefore, it can be assumed that vessel area and wall thickness were not significantly changed, and that the time for catheter drawback was short enough to maintain the same condition during PWV measurement. Data were digitized at 500 Hz on a personal computer and stored for subsequent offline analysis.

In 25 pre-Glenn patients in whom pulmonary flow was predominantly supplied via a Blalock-Taussig (BT) shunt, aortic volume flow was calculated as the sum of the pulmonary and systemic flow measured using the Fick principle and used to quantitatively assess the aortic volume load.

Statistical Analysis

All continuous data are expressed as mean±SD. Comparison between 2 groups was done using unpaired t-test. Pearson’s correlation analysis was used to assess relationships between PWV and AOD. Analysis of covariance and multivariate regression were also performed to determine the independent effect of PWV on aortic dilatation, with the factors potentially influencing aortic dilatation included as independent variables. These factors were age, sex, blood pressure, and history of BT shunt. P<0.05 was considered statistically significant. All statistical analysis was done using JMP version 8.0 and GraphPad PRISM version 5.

Results

Table 1 summarizes patient characteristics. Age, male/female ratio, body weight, body mass index, arterial oxygen saturation, systolic and diastolic blood pressures, and hemoglobin at the time of catheterization were similar between the 2 groups. Underlying cardiac disease was also similar in the 2 groups. No significant difference was observed between the 2 groups in the use of medications that might potentially affect aortic dilation (angiotensin-converting enzyme inhibitor or β-blockers). Angiotensin type I receptor blocker was not used in any of these patients. Of note, the dilatation group had a greater prevalence of history of BT shunt than the non-dilatation group (P=0.0024), suggesting a potential importance of aortic volume load in causing aortic dilatation. Three patients in the dilatation group and 1 patient in the non-dilatation group had mild aortic regurgitation. No patient had moderate or severe regurgitation or aortic stenosis.

Table 1. Patient Characteristics
  Dilatation group
(n=31)
Non-dilatation group
(n=25)
P-value
Age (years) 3.5±0.7 4.5±0.7 0.340
Male (%) 58 56 0.877
Body weight (kg) 13.6±1.7 16.2±1.7 0.290
BMI 15.6±0.4 15.5±0.3 0.998
SaO2 (%) 85.1±1.3 88.7±1.5 0.072
SBP (mmHg) 92.6±2.7 87.2±2.7 0.170
DBP (mmHg) 56.7±2.7 58.0±3.4 0.769
Hemoglobin (mg/dl) 13.2±0.3 12.8±0.4 0.535
Diagnosis (n)
 SV 21 15 0.548
 PAIVS 6 5 0.952
 DORV 3 3 0.877
 TA 1 2 0.430
Post-BT shunt (n) 11 14 0.125
Post-Glenn (n) 14 5 0.048
Post-Fontan (n) 6 6 0.674
History of BT shunt (n) 29 15 0.0024
Medications
 ACEI 10 (32) 7 (33) 0.93
 β-blocker 9 (31) 5 (25) 0.68
Aortic root dimension (mm) 19.9±0.8 16.1±0.8 0.001
Aortic root dimension (% of normal) 170.9±2.9 125.5±3.2 <0.0001

Data given as mean±SD or n (%).

ACEI, angiotensin-converting enzyme inhibitor; BMI, body mass index; BT, Blalock-Taussig; DBP, diastolic blood pressure; DORV, double outlet right ventricle; PAIVS, pulmonary atresia with intact ventricular septum; SaO2, arterial oxygen saturation; SBP, systolic blood pressure; SV, single ventricle; TA, tricuspid atresia.

Aortic Dilatation and Aortic Stiffness

As shown in Figure A, PWV was significantly higher in the dilatation group than in the non-dilatation group (483.6±10.3 vs. 394.0±8.9 cm/s, P<0.001) after controlling for age and aortic pressure, factors known to influence PWV (P<0.001; analysis of covariance). Importantly, a strong positive correlation was noted between AOD and PWV, suggesting that increased arterial stiffness correlates with aortic root dilatation (r=0.76, P<0.001; Figure B). Multivariate analysis using age, sex, history of BT shunt and blood pressure, as well as PWV, as independent variables showed that only PWV correlated significantly with aortic root dilatation (P<0.001).

Figure.

(A) Comparison of pulse wave velocity (PWV) between patients with dilated aorta (>150% of normal) and non-dilated aorta (<150% of normal). (B) Correlation between PWV and aortic diameter (AOD) normalized to the reference value.

To further assess whether aortic stiffness is a determinant of aortic dilatation, independent of aortic volume load, we carried out multivariate analysis with aortic flow volume added to the independent variables as an index of aortic volume load (25 pre-Glenn patients whose aortic volume flow was directly calculated). On univariate analysis, aortic flow volume had a positive correlation with AOD (r=0.62, P=0.003). In contrast, on multivariate analysis, only PWV had a significant positive correlation with AOD (P<0.001; Table 2).

Table 2. Multivariate Indicators of Aortic Dilatation
Independent variable Coefficient SE P-value
PWV (cm/s) 0.64 0.1 0.002
Aortic flow (L·min–1·m–2) 0.74 2.4 0.214
Age (years) 0.74 1.5 0.813
BP (mmHg) 0.69 0.4 0.176

BP, blood pressure; PWV, pulse wave velocity.

Discussion

In clinical practice, aortic dilatation is often observed in patients with SiV circulation and causes significant aortic regurgitation that could adversely affect outcome of patients with Fontan circulation, a surgical goal in SiV patients.17 The present study has shown for the first time that an altered aortic wall property, which is consistent with a previous report of abnormal aortic medial histopathology,5 might contribute to aortic root dilatation independent of aortic volume load in patients with SiV circulation.

Progressive aortic dilatation has been well recognized in Marfan syndrome, and is an important clinical problem in the affected patients.18,19 This has also been observed in specific types of CHD such as bicuspid aortic valve5 and TOF,1 and the pathophysiology of these cardiac abnormalities has been investigated extensively.1,512 Importantly, these 3 diseases have the common feature of aortic medial pathology characterized by medial degradation that could weaken and stiffen the aortic wall.5,6,19 Indeed, a number of studies have reported increased aortic stiffness and its significant effect on aortic dilatation in these diseases.712 In agreement with these previous observations, the present study adds new data showing that aortic medial pathology may also be implicated in the mechanism of aortic dilatation observed in patients with SiV physiology. The increased aortic stiffness observed in the present SiV patients is consistent with data from an important study by Niwa et al, who showed that abnormal aortic medial histopathology, characterized by elastic fiber disruption, was observed in patients with SiV physiology analogous to that of the present patients, including double-outlet right ventricle, single ventricle, or tricuspid atresia.5 The importance of medial elastic fibers in preserving aortic elasticity has been clearly demonstrated in both animal and human studies.19,20 Thus, aortic wall stiffness measured by PWV may be useful as a surrogate marker of aortic medial pathology in patients with SiV.

Increased aortic stiffness, possibly reflecting aortic medial degradation, suggests an abnormal load-bearing capacity of the aorta. Consistent with this notion, increased aortic stiffness was an independent determinant of aortic dilatation in the present cohort of SiV patients. Importantly, according to the Moens-Korteweg equation, PWV increases as vessel diameter decreases and as the vessel elastic modulus (wall stiffness) increases.21 Therefore, the observed association between PWV and AOD, which is the inverse of that described by the Moens-Korteweg equation, strongly suggests a close link between aortic medial pathology (wall stiffening) and increased PWV, as well as an important role of aortic stiffening (increased PWV) in aortic dilatation in patients with SiV circulation.

In addition to aortic medial pathology, volume load on the aortic wall has been suggested as another important cause of the aortic dilatation observed in TOF.1 The present study also supports this possibility because a history of BT shunt, which could cause aortic volume load, was observed more frequently in patients with a dilated aorta, and because there was a significant correlation between aortic flow volume and AOD in subgroup analysis. On multivariate analysis, however, only aortic stiffness correlated with aortic dilatation in the present SiV circulation patients (Table 2). While the results further support the importance of aortic medial pathology in aortic dilatation, because of the limited number of patients studied, the pathophysiologic importance of aortic volume load needs to be elucidated in further studies (on the basis that volume load on the weakened aortic wall could help accelerate aortic dilatation).

The present study has several limitations. First, although the study hypothesis relied on the assumption that increased PWV reflects abnormal medial histopathology, there is no evidence that the present SiV circulation patients had any histological abnormalities. Second, studies of aortic medial histology and mechanical properties in TOF indicated that those abnormities are intrinsic because aortic medial degradation and increased stiffness were observed as early as a few days after birth.6,11 Whether changes in aortic mechanical properties in SiV patients are also intrinsic is worth investigation. In addition, aortic stiffness was increased in some but not all of the present SiV patients. Therefore, factors that cause aortic medial changes, including genetic background or disease specificity, need to be elucidated in future studies. In this regard, the blood lipid profile, which was not measured in this study, may also be an important determinant of aortic stiffness. The time course of aortic dilation and the critical time point, if it exists, when the dilation becomes a clinical problem remain to be elucidated. In addition, although the present study suggests a causative role of increased aortic stiffness in aortic root dilatation, this possibility should be confirmed by prospective studies investigating whether aortic stiffness precedes aortic dilatation and whether medical interventions that potentially ameliorate medial degradation, such as angiotensin type 1 receptor blockade,1,22 affect aortic stiffness and the associated clinical course of aortic dilatation. Finally, because most studies on aortic dilatation in TOF measured aortic root diameter at the sinotubular junction,1,611 we used the same methodology to ensure consistency and ease of comparison. The size of the aorta at the sinuses of Valsalva, however, may be more clinically relevant because the most important clinical problem associated with aortic root dilatation may be aortic regurgitation rather than aortic dissection/rupture. In this regard, 1 study that measured aortic size at both the sinuses of Valsalva and the sinotubular junction identified a very similar trend in changes between the 2 measurements,7 suggesting that the results would have been similar if aortic size had been measured at the sinuses of Valsalva instead of at the sinotubular junction.

Conclusions

In agreement with a finding of abnormal aortic medial histopathology in CHD patients with SiV circulation, aortic stiffness was increased and significantly associated with aortic dilatation. Because preservation of ventricular function is a key issue in establishing and maintaining good Fontan circulation,23,24 further studies to define the causative role of aortic stiffening and other potential factors in the development of aortic dilatation may provide important clinical information that could help reduce the progression of aortic dilatation and resultant aortic regurgitation.

Acknowledgments

We thank our colleagues at Saitama Medical University who performed catheterization and surgery.

References
  • 1.    Niwa K, Siu SC, Webb GD, Gatzoulis MA. Progressive aortic root dilatation in adults late after repair of tetralogy Fallot. Circulation 2002; 106: 1374–1378.
  • 2.    Bull K, Somerville J, Ty E, Spiegelhalter D. Presentation and attrition in complex pulmonary atresia. J Am Coll Cardiol 1995; 25: 491–499.
  • 3.    Capelli H, Ross D, Somerville J. Aortic regurgitation in tetrad of Fallot and pulmonary atresia. Am J Cardiol 1982; 49: 1979–1983.
  • 4.    Marelli AJ, Perloff JK, Child JS, Laks H. Pulmonary atresia with ventricular septal defect in adults. Circulation 1994; 89: 243–251.
  • 5.    Niwa K, Perloff JK, Bhuta SM, Laks H, Drinkwater DC, Child JS, et al. Structural abnormalities of great arterial walls in congenital heart disease: Light and electron microscopic analysis. Circulation 2001; 103: 393–400.
  • 6.    Tan JL, Davlouros PA, McCarthy KP, Gatzoulis MA, Ho SY. Intrinsic histological abnormalities of aortic root and ascending aorta in tetralogy of Fallot: Evidence of causative mechanism for aortic dilatation and aortopathy. Circulation 2005; 112: 961–968.
  • 7.    Chong WY, Wong WHS, Chiu SWC, Cheung YF. Aortic root dilatation and aortic elastic properties in children after repair of tetralogy of Fallot. Am J Cardiol 2006; 97: 905–909.
  • 8.    Senzaki H, Iwamoto Y, Ishido H, Matsunaga T, Taketazu M, Kobayashi T, et al. Arterial haemodynamics in patients after repair of tetralogy of Fallot: Influence on left ventricular after load and aortic dilatation. Heart 2008; 94: 70–74.
  • 9.    Cheung YF, Ou X, Wong SJ. Central and peripheral arterial stiffness in patients after surgical repair of tetralogy of Fallot: Implications for aortic root dilatation. Heart 2006; 92: 1827–1830.
  • 10.    Saiki H, Seki M, Masutani S, Senzaki H. Marked disparity in mechanical wall properties between ascending and descending aorta in patients with tetralogy of Fallot. Eur J Cardiothorac Surg 2012; 41: 570–573.
  • 11.    Seki M, Kurishima C, Kawasaki H, Masutani S, Senzaki H. Aortic stiffness and aortic dilation in infants and children with tetralogy of Fallot before corrective surgery: Evidence for intrinsically abnormal aortic mechanical property. Eur J Cardiothorac Surg 2012; 41: 277–282.
  • 12.    Seki M, Kurishima C, Saiki H, Masutani S, Arakawa H, Tamura M, et al. Progressive aortic dilation and aortic stiffness in children with repaired tetralogy of Fallot. Heart Vessel 2014; 29: 83–87.
  • 13.    Carey JA, Hamilton JRL, Hilton CJ, Dark JH, Forty J, Parry G, et al. Orthotopic cardiac transplantation for the failing fontan circulation. Eur J Cardiothorac Surg 1998; 14: 7–14.
  • 14.    Leung MP, Benson LN, Smallhorn JF, Williams WG, Trusler GA, Freedom RM. Abnormal cardiac signs after Fontan type of operation: Indicators of residua and sequelae. Br Heart J 1989; 61: 52–58.
  • 15.    Goff DA, Blume ED, Gauvreau K, Mayer JE, Lock JE, Jenkins KJ. Clinical outcome of fenestrated Fontan patients after closure: The first 10 years. Circulation 2000; 102: 2094–2099.
  • 16.    Hiromi I, Shinya T, Sonoe I, Kazumi K, Norio T, Izuru N, et al. Normal value of aortic size and morphological characteristics of the aorta in childhood evaluated by two-dimensional ultrasonography. Pediatr Cardiol Cardiac Surg 2010; 26: 219–226.
  • 17.    Lauren L, Ali Z. The adult with Fontan: A panacea without a cure? Circ J 2013; 77: 2672–2681.
  • 18.    Michael H, Andreas K, Kurt P, Petra W, Manfred V. Elastic properties of the ascending aorta in healthy children and adolescents. Circ J 2013; 77: 3007–3014.
  • 19.    Okamoto RJ, Xu H, Kouchoukos NT, Moon MR, Sundt TM. The influence of mechanical properties on wall stress and distensibility of the dilated ascending aorta. J Thorac Cardiovasc Surg 2003; 126: 842–850.
  • 20.    Marque V, Kieffer P, Gayraud B, Idjouadine IL, Ramirez F, Atkinson J. Aortic wall mechanics and composition in a transgenic mouse model of Marfan syndrome. Arterioscler Thromb Vasc Biol 2001; 21: 1184–1189.
  • 21.    O’Rourke MF, Staessen JA, Vlachopoulos C, Duprez D, Plante GE. Clinical applications of arterial stiffness; definitions and reference values. Am J Hypertens 2002; 15: 426–444.
  • 22.    Shores J, Berger KR, Murphy EA, Pyeritz RE. Progression of aortic dilatation and the benefit of long-term β-adrenergic blockade in Marfan’s syndrome. N Engl J Med 1994; 330: 1335–1341.
  • 23.    Masutani S, Saiki H, Kurishima C, Ishido H, Tamura M, Senzaki H. Heart failure with preserved ejection fraction in children: Hormonal imbalance between aldosterone and brain natriuretic peptide. Circ J 2013; 77: 2375–2382.
  • 24.    Ohuchi H, Ono S, Tanabe Y, Fujimoto K, Yagi H, Sakaguchi H, et al. Long-term serial aerobic exercise capacity and hemodynamic properties in clinically and hemodynamically good, “excellent”, Fontan survivors. Circ J 2012; 76: 195–203.
 
© 2014 THE JAPANESE CIRCULATION SOCIETY
feedback
Top